Vimentin autoantibodies induce platelet activation and formation of platelet-leukocyte conjugates via platelet-activating factor
- 1 November 2007
- journal article
- Published by Oxford University Press (OUP) in Journal of Leukocyte Biology
- Vol. 83 (2) , 263-271
Abstract
Anti-vimentin antibodies (AVA) are associated with autoimmunity and solid organ transplantation, conditions associated with vascular disease, but their contribution to disease pathogenesis is unknown. Here, we have examined interactions between AVA (mAb and serum from patients) and various leukocyte populations using whole blood and flow cytometry. Normal blood treated with patient sera containing high AVA-IgM titers or with a vimentin-specific monoclonal IgM led to activation of platelets and other leukocytes, as demonstrated by induced expression of P-selectin, fibrinogen, tissue factor, and formation of platelet:leukocyte (P:L) conjugates and a reduction in platelet counts. This activity was antigen (vimentin)-specific and was not mediated by irrelevant IgM antibodies. Flow cytometry demonstrated that AVA do not bind directly to resting platelets in whole blood, but they bind to ∼10% of leukocytes. Supernatant, derived from AVA-treated leukocytes, induced platelet activation, as measured by the generation of platelet microparticles, when added to platelet-rich plasma. When AVA were added to whole blood in the presence of CV-6209, a platelet-activating factor (PAF) receptor inhibitor, platelet depletion was inhibited. This suggests that PAF is one of the mediators released from AVA-activated leukocytes that leads to P:L conjugation formation and platelet activation. In summary, AVA bind to leukocytes, resulting in release of a PAF and prothrombotic factor that exert a paracrine-activating effect on platelets. Overall, this proposed mechanism may explain the pathogenesis of thrombotic events in autoimmune diseases associated with AVA.Keywords
Funding Information
- BHF (FS/05/124/19972)
- CIHR IOPG
- CIHR (20R90839)
- BTS Fellowship
- BHF (RG/2001005)
This publication has 44 references indexed in Scilit:
- Autoantibodies to Vimentin Cause Accelerated Rejection of Cardiac AllograftsThe American Journal of Pathology, 2007
- The Interface Between Coagulation and ImmunityAmerican Journal of Transplantation, 2007
- Pathogenic role of anti-neutrophil cytoplasmic antibodies in vasculitisCurrent Opinion in Pharmacology, 2006
- Lysophospholipid transacetylase in the regulation of PAF levels in human monocytes and macrophagesThe FASEB Journal, 2006
- De novo production of antibodies after heart or lung transplantation should be regarded as an early warning systemThe Journal of Heart and Lung Transplantation, 2004
- Increased leukocyte-platelet adhesion in patients with graft occlusion after peripheral vascular surgeryThrombosis and Haemostasis, 2003
- Correlation of anti-vimentin antibodies with acute and chronic rejection following cardiac transplantationHuman Immunology, 2002
- Identification of a Caspase-9 Substrate and Detection of Its Cleavage in Programmed Cell Death during Mouse DevelopmentJournal of Biological Chemistry, 2001
- Lupus autoantibodies interact directly with distinct glomerular and vascular cell surface antigensKidney International, 1996
- Autoantibodies Against Vimentin in a Murine Model of MyocarditisAutoimmunity, 1994